In The News
Google faces potential class action over AdTech dominance
High Court cases could push Blue Sky class action trial to 2026
Dominique Grubisa’s companies illegally scraped court websites: OAIC
Court approves landmark $75M detention centre class action settlement
Burger ad beef between McDonald’s, Hungry Jack’s done
Bubble tea chain Chatime fined for underpaying staff
Class action probe accuses union of forcing staff to join Labor Party
Travelex wins opposition to blockchain tech company’s trade marks
Collapsed Mosaic Brands owes creditors over $245M
Class action firm breaches costs disclosure rules again, fights penalty
Please login to bookmarkClose

Israeli drug giant Teva and German drug maker Boehringer Ingelheim have settled their dispute over a patented capsule used to deliver the medicine in Boehringer’s top-selling inhaler Spiriva.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au